azomycin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Chen, D; Ding, Y; He, C; Hu, C; Liu, D; Liu, P; Tang, Q; Wang, X; Yang, R; Yu, W; Zhang, Z | 1 |
| Ham, SL; Joshi, R; Luker, GD; Tavana, H | 1 |
2 other study(ies) available for azomycin and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Chitosan; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nitroimidazoles; Oligosaccharides; Optical Imaging; Phosphoramide Mustards; Photochemotherapy; Photosensitizing Agents; Prodrugs; Triple Negative Breast Neoplasms | 2021 |
Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Engineering; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Extracellular Matrix Proteins; Female; Humans; Hypoxia; Neoplastic Stem Cells; Nitroimidazoles; Phosphoramide Mustards; Polymers; Prodrugs; Spheroids, Cellular; Triple Negative Breast Neoplasms | 2016 |